UNLYD Stock Price (+0.61) | Stock Quote, Chart & News for Unilever Plc on Fox Business

Unilever Plc, a global consumer-goods group operating across Beauty & Wellbeing, Personal Care, Home Care, Nutrition and Ice Cream, generated $65.72bn of revenue and $6.21bn of net income with c.2% sales growth in 2024 and about 120,040 employees. The company exhibits strong profitability and capital efficiency (gross margin 45.0%, operating margin 18.4%, net margin 9.5%, ROE 30.5%, ROIC 13.5%) and trades at a moderate valuation (P/E 23.4, P/S 2.17, EV/EBITDA 12.2), but has below‑par liquidity (current ratio 0.76, quick ratio 0.56) and relatively high leverage metrics (total debt/equity ~153%, long‑term debt/equity ~122%), presenting a stable cash‑generative consumer‑staples story where balance‑sheet risk warrants monitoring alongside steady earnings generation.

Analysis

Unilever Plc is presented as a diversified consumer-goods operator across Beauty & Wellbeing, Personal Care, Home Care, Nutrition and Ice Cream that generated $65.72bn of revenue and $6.21bn of net income with roughly 1.995% sales growth for 2024 and 120,040 employees. The company’s segment mix supports stable cash flows but top-line growth is modest relative to the scale of the business.

Profitability metrics are strong: gross margin 45.045%, operating margin 18.393% and net margin 9.453%, supporting high capital efficiency (ROE 30.535%, ROIC 13.479%). Market multiples are moderate with P/E 23.42, P/S 2.173 and EV/EBITDA 12.24, implying the market prices a degree of earnings stability but limited growth upside.

Balance-sheet metrics are the principal risk: current ratio 0.761, quick ratio 0.555 and cash ratio 0.296 indicate below-par near-term liquidity while leverage is elevated (total debt/equity ~153.4%, long-term debt/equity ~122.3%, debt/EV 0.187). Sentiment readings are mixed/cautious (sentiment score -0.05) with low market-impact (0.22), so momentum support is weak and balance-sheet developments should drive re-rating.

Key Decisions for Investors

• Favor a neutral to modestly bullish stance—Unilever’s strong margins and ROIC justify maintaining exposure but avoid aggressive position increases given sub-2% sales growth and only moderate valuation
• Prioritize monitoring liquidity and leverage metrics closely (current ratio, cash ratio, total debt/equity) and be prepared to trim or hedge if management guidance or debt-servicing indicators worsen
• Consider opportunistic incremental buys on meaningful share-price weakness if fundamentals remain intact and sales growth trends improve, given mixed market sentiment and limited immediate market impact